A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome Peggy A. Wu, Youn H. Kim, Phillip W. Lavori, Richard T. Hoppe, Keith E. Stockerl-Goldstein Biology of Blood and Marrow Transplantation Volume 15, Issue 8, Pages 982-990 (August 2009) DOI: 10.1016/j.bbmt.2009.04.017 Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 1 OS of patients with MF receiving an allogeneic transplant (allo) or an autologous transplant (auto), P = .027. Biology of Blood and Marrow Transplantation 2009 15, 982-990DOI: (10.1016/j.bbmt.2009.04.017) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 2 EFS of patients with MF receiving an allogeneic transplant (allo) or an autologous transplant (auto), P = .0021. Biology of Blood and Marrow Transplantation 2009 15, 982-990DOI: (10.1016/j.bbmt.2009.04.017) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 3 Estimated cumulative incidences of cancer (CA) and noncancer (nonCA) mortality in allogeneic (allo) and (auto) autologous transplant groups. Biology of Blood and Marrow Transplantation 2009 15, 982-990DOI: (10.1016/j.bbmt.2009.04.017) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions